339 related articles for article (PubMed ID: 24060424)
1. Modulation of the foreign body response to implanted sensor models through device-based delivery of the tyrosine kinase inhibitor, masitinib.
Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F
Biomaterials; 2013 Dec; 34(38):9737-46. PubMed ID: 24060424
[TBL] [Abstract][Full Text] [Related]
2. Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kit(w-Sh) murine model.
Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F
Acta Biomater; 2014 May; 10(5):1856-63. PubMed ID: 24406200
[TBL] [Abstract][Full Text] [Related]
3. Local release of masitinib alters in vivo implantable continuous glucose sensor performance.
Avula M; Jones D; Rao AN; McClain D; McGill LD; Grainger DW; Solzbacher F
Biosens Bioelectron; 2016 Mar; 77():149-56. PubMed ID: 26402593
[TBL] [Abstract][Full Text] [Related]
4. Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
Wang Y; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2013 Aug; 169(3):341-7. PubMed ID: 23298616
[TBL] [Abstract][Full Text] [Related]
5. Reduced foreign body reaction to implanted biomaterials by surface treatment with oriented osteopontin.
Liu L; Chen G; Chao T; Ratner BD; Sage EH; Jiang S
J Biomater Sci Polym Ed; 2008; 19(6):821-35. PubMed ID: 18534099
[TBL] [Abstract][Full Text] [Related]
6. Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.
Kastellorizios M; Tipnis N; Papadimitrakopoulos F; Burgess DJ
Mol Pharm; 2015 Sep; 12(9):3332-8. PubMed ID: 26237140
[TBL] [Abstract][Full Text] [Related]
7. Prevention of foreign body reaction in a pre-clinical large animal model.
Kastellorizios M; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2015 Mar; 202():101-7. PubMed ID: 25645376
[TBL] [Abstract][Full Text] [Related]
8. Foreign Body Reaction to Implantable Biosensors: Effects of Tissue Trauma and Implant Size.
Wang Y; Vaddiraju S; Gu B; Papadimitrakopoulos F; Burgess DJ
J Diabetes Sci Technol; 2015 Aug; 9(5):966-77. PubMed ID: 26306495
[TBL] [Abstract][Full Text] [Related]
9. Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery.
Kyriakides TR; Hartzel T; Huynh G; Bornstein P
Mol Ther; 2001 Jun; 3(6):842-9. PubMed ID: 11407897
[TBL] [Abstract][Full Text] [Related]
10. Glucose sensor membranes for mitigating the foreign body response.
Koh A; Nichols SP; Schoenfisch MH
J Diabetes Sci Technol; 2011 Sep; 5(5):1052-9. PubMed ID: 22027297
[TBL] [Abstract][Full Text] [Related]
11. Long-term sustained release of salicylic acid from cross-linked biodegradable polyester induces a reduced foreign body response in mice.
Chandorkar Y; Bhaskar N; Madras G; Basu B
Biomacromolecules; 2015 Feb; 16(2):636-49. PubMed ID: 25559641
[TBL] [Abstract][Full Text] [Related]
12. A self-cleaning, mechanically robust membrane for minimizing the foreign body reaction: towards extending the lifetime of sub-Q glucose biosensors.
Means AK; Dong P; Clubb FJ; Friedemann MC; Colvin LE; Shrode CA; Coté GL; Grunlan MA
J Mater Sci Mater Med; 2019 Jun; 30(7):79. PubMed ID: 31240399
[TBL] [Abstract][Full Text] [Related]
13. Biomedical implant capsule formation: lessons learned and the road ahead.
DiEgidio P; Friedman HI; Gourdie RG; Riley AE; Yost MJ; Goodwin RL
Ann Plast Surg; 2014 Oct; 73(4):451-60. PubMed ID: 25046663
[TBL] [Abstract][Full Text] [Related]
14. Bijel-templated implantable biomaterials for enhancing tissue integration and vascularization.
Thorson TJ; Gurlin RE; Botvinick EL; Mohraz A
Acta Biomater; 2019 Aug; 94():173-182. PubMed ID: 31233892
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin regulates host foreign-body reaction to polyetheretherketone implants via miR-29ab1-mediated SLIT3 upregulation.
Liao Y; Ouyang L; Ci L; Chen B; Lv D; Li Q; Sun Y; Fei J; Bao S; Liu X; Li L
Biomaterials; 2019 May; 203():12-22. PubMed ID: 30851489
[TBL] [Abstract][Full Text] [Related]
16. Localized immunosuppressive environment in the foreign body response to implanted biomaterials.
Higgins DM; Basaraba RJ; Hohnbaum AC; Lee EJ; Grainger DW; Gonzalez-Juarrero M
Am J Pathol; 2009 Jul; 175(1):161-70. PubMed ID: 19528351
[TBL] [Abstract][Full Text] [Related]
17. Fibrous capsule formation in response to ultrahigh molecular weight polyethylene treated with peptides that influence adhesion.
Johnson R; Harrison D; Tucci M; Tsao A; Lemos M; Puckett A; Hughes JL; Benghuzzi H
Biomed Sci Instrum; 1997; 34():47-52. PubMed ID: 9603011
[TBL] [Abstract][Full Text] [Related]
18. Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants.
Kastellorizios M; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2015 Sep; 214():103-11. PubMed ID: 26216396
[TBL] [Abstract][Full Text] [Related]
19. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction.
Sussman EM; Halpin MC; Muster J; Moon RT; Ratner BD
Ann Biomed Eng; 2014 Jul; 42(7):1508-16. PubMed ID: 24248559
[TBL] [Abstract][Full Text] [Related]
20. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.
Takahashi H; Wang Y; Grainger DW
J Control Release; 2010 Nov; 147(3):400-7. PubMed ID: 20727922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
